Phase II trial of temozolomide in patients with progressive low-grade glioma.
Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM, McLendon RE, Gururangan S, Bigner DD, Herndon JE 2nd, Avgeropoulos N, Finlay J, Tourt-Uhlig S, Affronti ML, Evans B, Stafford-Fox V, Zaknoen S, Friedman HS.
Quinn JA, et al. Among authors: friedman hs, friedman ah.
J Clin Oncol. 2003 Feb 15;21(4):646-51. doi: 10.1200/JCO.2003.01.009.
J Clin Oncol. 2003.
PMID: 12586801
Clinical Trial.